These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23384036)

  • 1. Safety monitoring of artemisinin combination therapy through a national pharmacovigilance system in an endemic malaria setting.
    Thiam S; Ndiaye JL; Diallo I; Gatonga P; Fall FB; Diallo NE; Faye B; Diouf ML; Ndiop M; Diouf MB; Gaye O; Thior M
    Malar J; 2013 Feb; 12():54. PubMed ID: 23384036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal.
    Brasseur P; Vaillant MT; Olliaro PL
    Malar J; 2012 Dec; 11():402. PubMed ID: 23216982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso.
    Rouamba T; Sondo P; Derra K; Nakanabo-Diallo S; Bihoun B; Rouamba E; Tarnagda Z; Kazienga A; Valea I; Sorgho H; Pagnoni F; Samadoulougou-Kirakoya F; Tinto H
    Drug Des Devel Ther; 2020; 14():1507-1521. PubMed ID: 32368010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.
    Dodoo AN; Fogg C; Nartey ET; Ferreira GL; Adjei GO; Kudzi W; Sulley AM; Kodua A; Ofori-Adjei D
    Drug Saf; 2014 Jun; 37(6):433-48. PubMed ID: 24788801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.
    Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI
    Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
    Baiden R; Oduro A; Halidou T; Gyapong M; Sie A; Macete E; Abdulla S; Owusu-Agyei S; Mulokozi A; Adjei A; Sevene E; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Ogutu B; Upunda GL; Smith P; Binka F
    Malar J; 2015 Apr; 14():160. PubMed ID: 25885858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania.
    Shayo A; Buza J; Ishengoma DS
    Malar J; 2015 Mar; 14():135. PubMed ID: 25889242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in malaria morbidity following the introduction of artesunate plus amodiaquine combination in M'lomp village dispensary, south-western Senegal.
    Sarrassat S; Senghor P; Le Hesran JY
    Malar J; 2008 Oct; 7():215. PubMed ID: 18950485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience.
    Bompart F; Kiechel JR; Sebbag R; Pecoul B
    Malar J; 2011 May; 10():143. PubMed ID: 21605364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.
    Thanh NX; Trung TN; Phong NC; Quang HH; Dai B; Shanks GD; Chavchich M; Edstein MD
    Malar J; 2012 Jun; 11():217. PubMed ID: 22741618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.
    Dellicour S; Brasseur P; Thorn P; Gaye O; Olliaro P; Badiane M; Stergachis A; ter Kuile FO
    Drug Saf; 2013 Jul; 36(7):505-13. PubMed ID: 23673815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana.
    Chatio S; Aborigo R; Adongo PB; Anyorigiya T; Dalinjong PA; Akweongo P; Oduro A
    Malar J; 2016 Feb; 15():125. PubMed ID: 26921239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
    Osorio L; Gonzalez I; Olliaro P; Taylor WR
    Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
    Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N
    PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.